(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 15
Annual BIO CEO & Investor Conference on Tuesday, Feb. 12, 2013, at 1:00 p.m. EST (6:00 p.m. GMT) from the Waldorf Astoria Hotel in New York City. In addition, Alkermes’ corporate presentation will be webcast live at the Leerink Swann Global Healthcare Conference 2013 on Wednesday, Feb. 13, 2013, at 3:00 p.m. EST (8:00 p.m. GMT), also from the Waldorf Astoria Hotel in New York City. These presentations may be accessed under the Investors tab on
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at